Register entry

Chengdu Shengnuo Biopharm Co., Ltd.

Registered sites
1
Drug products
15
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Active ingredient (API) manufacture
Sites

Facilities

1
SiteLocationOperationsFEI
Chengdu Shengnuo Biopharm Co., Ltd.Dayi CountyChinaActive ingredient (API) manufacture3006257504
Catalogue

Marketed products

15

Showing 15 of 15.

BrandGeneric nameFormCategory
-AbaloparatidePOWDERBULK INGREDIENT
-EptifibatidePOWDERBULK INGREDIENT
-Ganirelix AcetatePOWDERBULK INGREDIENT
-Icatibant AcetatePOWDERBULK INGREDIENT
-Lanreotide AcetatePOWDERBULK INGREDIENT
-LinaclotidePOWDERBULK INGREDIENT
-LiraglutidePOWDERBULK INGREDIENT
-Octreotide AcetatePOWDERBULK INGREDIENT
-SemaglutidePOWDERBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-SemaglutidePOWDERBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-TeriparatidePOWDERBULK INGREDIENT
-Terlipressin AcetatePOWDERBULK INGREDIENT
-TirzepatidePOWDERBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Ziconotide AcetatePOWDERBULK INGREDIENT
-bivalirudinPOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.